Yumeng Wang is a vice president at General Atlantic, primarily responsible for investments in healthcare and life sciences sectors. Prior to joining General Atlantic, Ms. Wang served as an equity research analyst at The Hongkong and Shanghai Banking Corporation, mainly focusing on the healthcare sector. Ms. Wang also serves as a non-executive director of Ocumension Therapeutics (1477.HK) and Adagene Inc (NASDAQ: ADAG). Ms. Wang received her bachelor’s degree in business administration in 2013 and her master's degree in biotechnology in 2021 from The Hong Kong University of Science and Technology.